N/A N=4,451 Randomized Other

Awareness Enhancing Interventions

Research Awareness

Bottom Line

View on ClinicalTrials.gov: NCT04683510 ↗

Enrolled (actual)

4,451

Serious AEs

—

Results posted

May 2025

Primary outcome: Primary: Recruitment Yield — 13; 33; 37 participants — p=0.2345

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Navigation - Study Specific - Researcher Voice (Other); Navigation - Study Specific - Cancer Survivor Voice (Other); Navigation - Research General - Researcher Voice (Other); Navigation - Research General - Cancer Survivor Voice (Other); Brochure - Study Specific - Researcher Voice (Other); Brochure - Study Specific - Cancer Survivor Voice (Other); Brochure - Research General - Researcher Voice (Other); Brochure - Research General - Cancer Survivor Voice (Other)
Age: Adult, Older Adult · 50+ yrs
Sex: All
Sponsor: University of Tennessee
Primary completion: Mar 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Recruitment Yield	13; 33; 37	0.2345

Summary

The purpose of this study is to determine if increasing awareness and, thus, enhancing positive attitudes about research, prior to recruitment attempts, will increase participation in cancer clinical research among African American (AA) cancer survivors so that recruitment efforts can focus on the most optimal and cost- effective approaches

Eligibility Criteria

Inclusion Criteria

African American/Black
adults (age ≥50 years old)
diagnosed with obesity/physical activity associated cancers that have a 70% or greater 5-year relative cancer-free survival rate multiple myeloma, localized kidney cancer and loco- regional cancers of the colorectum, female breast, prostate, endometrium, and ovary).
1-5 years post diagnosis
reside in an area with wireless coverage
In the AMPLIFI recruitment pool

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04683510). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.